KR20130103834A - A cigarette filter containing rosemary extract and a method of reducing dna damage caused by harmful agents in cigarette smoke by use of said filter - Google Patents

Abstract

The present invention relates to tobacco filters comprising rosemary extracts and methods of reducing DNA damage caused by various harmful substances in tobacco smoke. More specifically, the present invention relates to a method for reducing DNA damage caused by benzo (a) pyrene in human cells by reducing the benzo (a) pyrene diol epoxide-dG (BPDE-dG) adduct in human lungs. It relates to the use of the filter.

Description

Cigarette filter comprising rosemary extract and a method of using the filter to reduce DNA damage caused by harmful substances in cigarette smoke. USE OF SAID FILTER}

The present invention relates to tobacco filters comprising rosemary extracts and methods of reducing DNA damage caused by various harmful substances in tobacco smoke. More specifically, the present invention relates to a method for reducing DNA damage caused by benzo (a) pyrene in human cells by reducing the benzo (a) pyrene diol epoxide-dG (BPDE-dG) adduct in human lungs. It relates to the use of the filter.

The benzo (a) pyrene diol epoxide-dG (BPDE-dG) adduct of the human lung is concentrated in bronchial cells. This adduct is currently recognized to play a critical role in oncogenesis by benzo (a) pyrene. Tobacco smoke is a major contributor to BPDE-dG formation. Tobacco is clearly used as a model for understanding cancer induction mechanisms because it is most commonly associated between exposure to known carcinogens and death from cancer. Benzo (a) pyrene (BP) is an extremely carcinogenic polycyclic aromatic hydrocarbon (PAH) present in exhaust gas, charcoal-grilled foods, present in tobacco smoke in small amounts, typically less than 10 ng per cigarette. BP is one of more than 60 carcinogens in tobacco smoke associated with the pathogenesis of lung cancer. It is metabolically activated to benzo (a) pyrene-7,8-diol-9,10-epoxide (BPDE), which reacts with DNA, primarily at the N ² -position of guanine, primarily N ² -guanine lesions For example, benzo (a) pyrene-7,8-diol-9,10-epoxide-N ² -deoxyguanosine (BPDE-dG) adduct. The presence of BPDE-DNA adducts in human tissues is established and the BPDE-dG adducts are exclusively concentrated in bronchial cells, thus affecting the onset of human lung cancer.

Rosemary ( Rosmarinus officinalis Labiatae ) herbs and oils, rosemary extracts, carnosic acid and carnosol are commonly used in food processing as spices and flavoring agents for the purpose of desired flavor and high antioxidant activity.

However, prior to the present invention, the use of rosemary extract in tobacco filters is known to play a decisive role in tumorigenesis by benzo (a) pyrene, in particular, benzo (a) pyrene. It is not known that pyrene diol epoxide-dG (BPDE-dG) adducts can reduce DNA damage caused in human cells.

The present invention provides tobacco filters comprising rosemary extracts and methods of reducing DNA damage caused by various harmful substances in tobacco smoke.

Summary of the Invention

As can be seen in this study, BP is recognized as a major carcinogen associated with lung cancer induction in smokers, and reactive oxygen species contribute substantially to the production of crucial lung cancer forming adducts. Preventing tobacco addiction and increasing the efficiency of smoking cessation and reduction programs are all important, but this approach has little effect. Preventing the production of BPDE-dG adducts is one approach to reducing lung cancer risk in addiction smokers.

The present invention relates to tobacco filters comprising rosemary extracts and methods of reducing DNA damage caused by harmful substances in tobacco smoke. More specifically, the present invention provides a method of reducing the damage to DNA caused by benzo (a) pyrene in human cells by reducing the benzo (a) pyrene diol epoxide-dG (BPDE-dG) adduct in the human lung. Provides the use of a filter.

(-) - it was found in that it linearly increases with the smoke concentration in the presence of BP-7,8- diol-anti amount (anti) -BPDE-dG adduct, (+). Catalase and superoxide dismutase inhibit its production by more than 80%. When MCF-7 cells were treated with (+)-BP-7,8-diol for 2 hours, tobacco smoke increased the production of (-)-anti-BPDE-dG dose-dependently, and the adduct (+)- It reduces CYP depending on the production of syn- BPDE.

Cells were treated with benzo (a) pyrene for 1 day and then exposed to tobacco smoke for 2 hours. During these two hours, it was found that due to CYP activity, the adduct production was doubled in tobacco smoke treated cells compared to untreated cells. Thus, it has been found that tobacco smoke activates the second stage of the metabolic pathway of benzo (a) pyrene leading to the production of BPDE-dG adducts by the reactive oxygen species it contains.

Tobacco smoke can thus lead to the production of crucial lung cancer forming adjuncts in this pathway.

Finally, a modified tobacco filter comprising rosemary extract was found to reduce the level of BPDE-dG adduct due to tobacco smoke in MCF-7 cells by more than 70%. These findings are believed to have made significant strides in reducing the risk of lung cancer in addicted smokers.

Experimental Plan  And a brief description of the table

Experimental Method 1. MCF-7 cells were treated with BP for 12 and 18 hours, followed by tobacco smoke with BP for an additional 2 hours (tests A and B, respectively). The purpose of this test is to determine the effects of activating BP to different degrees, producing BP-7,8-diol, and taking place during the last two hours after treating the cells with tobacco smoke. The control group was treated with only BP cells.

Table 1. Effect of scavenger on BPDE-dG induced by tobacco smoke in cell-free system

process BPDE-dG for% Standard CS Standard CSS 100    + Superoxide dismutase SOD (20 μg) 16    + Catalase (4 μg) 12    + Inert catalase (4 μg) 100 CSS filtered with rosemary instead of standard CSS 42

The standard CSS system includes 2 ml of calf thymus DNA (3 mg / ml), 600 μl 30 μM (+) BaP-7,8-diol and 5 ml CSS (1:19) diluted with PBS at pH 7.4. Incubated at room temperature for 2 hours. Each value was obtained from three independent experiments performed twice. The mean error was about 12% in each of the two trials. The BPDE-dG value of the standard CSS was an adjunct of 56 ± 6.3 (mean ± s.d.) Per mg DNA.

 The filter of the present invention reduces the DNA damage caused by benzo (a) pyrene in human cells by reducing the benzo (a) pyrene diol epoxide-dG (BPDE-dG) adduct in human lungs.

Figure 1. Carcinogens benzo (a) a major metabolic pathway, and DAN combination of pyrene: benzo (a) pyrene has been converted by the enzyme, or in the active oxygen species in vivo, to create a reactive DNA- dihydro-diol epoxide , Is a carcinogen of tobacco. From (-)-BP-7,8-dihydrodiol, mutagenic (+)-r-7, t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetra Stereoselective generation of hydro-BP [(+)-anti-BPDE] is catalyzed by cytochrome-P450-dependent monooxygenase (P450) or active oxygen species. The subsequent reaction of reacting these electrophilic intermediates with genomic DNA forms a stable adduct between the exocyclic amino group of guanosine and the dihydrodiol epoxide. DNA lesions of this kind can be converted to mutations in the next replication cycle, unless repair of the adduct is made.
Figure 2. Results obtained by using a cell-free system, involving the additional DNA: water 2 ml of 6 mg calf thymus DNA dilution is added to another 5 ml of the CSS, at room temperature for 2 hours, (+) - BP- It was reacted with 7,8-diol (final concentration 3.6 μM). DNA was hydrolyzed and effluent BP-tetrol I was measured as described in the following materials and methods.
Figure 3. (a) peroxide radicals and stereochemistry and (b) of the epoxidation of a by the cytochrome P450, BP-7,8- diol can bind to DNA in the active species (anti -BPDE and new -BPDE) present Acid hydrolysis of DNA measured in the study into BP-tetrol. Hydrolysis of (-)-anti-BPDE-dG and (-)-cine-BPDE produces BP-tetrol I-2 and BP-tetrol II-l, but they are unstable and thus BP-tetrol Il and BP- Converts to Tetrol II-2.
4. Results obtained using MFC-7 cells. A total volume of 20 ml 10 × 10 ⁶ cells / 150 cm ² flasks were treated for 2 hours in the presence of (+)-BP-7,8-diol (0.2 μM) alone or other dilutions of CSS. After DNA isolation and hydrolysis, the spilled BP-tetrol was measured and the level of binding was measured as described in the materials and methods below. Two different peaks were observed in chromatograms corresponding to BP-tetrol I and BP-tetrol II derived from (-)-anti-BPDE-dG and (+)-cine-BPDE-dG, respectively (see 32-34). Values represent mean + Std in two independent experiments analyzed by 3-4 HPLC. 4A , top panel, increase of (-)-anti-BPDE-dG adduct with CSS dilution; 4B , bottom panel, increase of 1 / (+)-new-BPDE-dG adduct with CSS dilution
5. BPDE-dG binding in MCF-7 cells after exposure to BP 2.5 μM or BP 2.5 μM + CS solution (20-fold dilution) for a defined time. Tobacco smoke solution was added during the last 2 hours of exposure to BP (Experiment 1). BPDE-dG analysis was performed as described in the materials and methods below. Numbers represent mean plus standard deviation in two independent experiments analyzed with 4-6 HPDC. The BPDE-dG value was an adduct of 11.7 ± 0.5 (mean ± sd) Dg per mg DNA after 12 hours of incubation, and 17.6 ± 0.4 and 26.1 ± 0.9, respectively, after 18 and 24 hours. For 2 hours after each baseline time of 12, 18 and 24 hours, these values increased to 17.2 ± 0.5, 27.8 ± 0.8, and 42.2 ± 1.0 due to spontaneous metabolism of CYP. Addition of Tobacco Smoke Solution (CSS) resulted in the final value of BPDE-dG as adducts of 36.9 ± 1.2, 56.7 ± 0.9 and 80.2 ± 1.2 (mean ± sd) per mg during the same 2 hours after 12, 18 and 24 hours, respectively. Increased, leading to more dramatic changes.
Figure 6. BPDE-dG binding in MCF-7 cells after exposure to BP 2.5 μM or BP 2.5 μM + CS solution obtained from standard filter and rosemary extract containing filter. Tobacco smoke solution was added during the last 2 hours of the designated time of exposure to BP (Experiment 1). Analysis of BPDE-dG was performed as described in the materials and methods below. HPLC analysis showed only one peak in the chromatogram corresponding to BP-tetrol I from (+)-anti-BPDE-dG. Numbers represent mean + Std in two independent experiments analyzed by 4-6 HPLC.

Tobacco smoke is associated with the cause of many human cancers. Tobacco is clearly used as a model for understanding cancer induction mechanisms because it is most commonly associated between exposure to known carcinogens and death from cancer.

Benzo (a) pyrene (BP) is an extremely carcinogenic polycyclic aromatic hydrocarbon (PAH) present in exhaust gas, charcoal-grilled foods, present in tobacco smoke in small amounts, typically less than 10 ng per cigarette. BP is one of more than 60 carcinogens in tobacco smoke associated with the pathogenesis of lung cancer. It is metabolically activated to benzo (a) pyrene-7,8-diol-9,10-epoxide (BPDE), which reacts with DNA, primarily at the N ² -position of guanine, leading to N ² -guanine damage For example, benzo (a) pyrene-7,8-diol-9,10-epoxide-N ² -deoxyguanosine (BPDE-dG) adduct.

The presence of BPDE-DNA adducts in human tissues is established and the BPDE-dG adducts are exclusively concentrated in bronchial cells, thus affecting the onset of human lung cancer.

This carcinogen is metabolized by phase I enzymes to produce a number of metabolites including phenol, arene oxide, quinone, dihydrodiol and diol epoxide. A schematic diagram of the BP metabolic pathway producing the (+)-anti-BPDE-dG adduct is shown in FIG. 1.

More specifically, two rounds of cytochrome P450-mediated oxidation resulted in the final carcinogen (+)-anti-BPDE from BP. The first step of this oxidation is to produce (-)-7,8-dihydro-7,8-dihydrobenzo (a) pyrene [(-) BP-7,8-diol]. The diol is primarily highly mutagenic (+)-r-7, t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydro-BP [(+)-anti -BPDE]. In various studies, it was confirmed that [(+)-anti-BPDE] is the primary carcinogenic metabolite of BP that exhibits improved mutant activity in vivo and in vitro. Most previous studies of genetic variation in the metabolism of lung carcinogens have focused on the metabolic activity by various cytochrome P450s, despite the generally low expression of cytochrome P450 in the lungs. Activation of BP-7,8-diol by lung epithelial cells is not only caused by classical CYPs / GSTs dependent biotransformation processes, but is also associated with other metabolic pathways other than CYPs. This includes lipooxygenase, lipid-peroxide and peroxidase-dependent pathways, COX-I and COX-2.

Many evidence suggests the causal importance of tobacco free radicals in inducing lung cancer in smokers. Each blow of tobacco produces more than 10 trillion free radicals, which can contribute to the initiation of tumors as well as the promotion of various forms of human cancer caused by repeated attacks by ROS on cellular macromolecules. The main free radical species is required to be an equilibrium mixture of semiquinones, hydroquinones and quinones. This free radical mixture is thought to cause a redox cycle that produces superoxide anions from molecular oxygen and forms hydrogen peroxide and hydroxyl radicals. These reactive species cause single chain breakdown and DNA nicking of DNA in cultured rodent and human cells. Quinone-related redox cycles may also be related to these effects; Hydroquinone and catechol are believed to play a major role.

In the present invention, tobacco smoke is, by its oxygen-producing radicals, thought to be (+)-r-7, t-8-dihydroxy-t- from (-)-BP-7,8-diol in the cell. Metabolism with 9,10-oxy-7,8,9,10-tetrahydro-BP [(+)-anti-BPDE] activates the second stage of the BP metabolic pathway leading to the production of BPDE-dG adducts It was found that it can (Figure 1).

It has also been found that the activation is promoted at least twice as much as that obtained in CYPs devices.

It has also been found that ROS derived from tobacco smoke may be responsible for the production of partially increased BPDE-dG adducts.

Also in the present invention, a filter comprising a rosemary powder formulation can significantly reduce the level of BPDE-dG due to CS oxygen producing radicals, and this finding reduces the production of BPDE-dG adducts that are carcinogens in bronchial epithelial cells. It has been found that it can be applied to tobacco filters.

The present invention provides a method for measuring the relative contribution of ROS in tobacco smoke compared to cytochrome P450 in activation of BP-7,8-diol; (ii) means for ascertaining whether ROS in tobacco smoke promotes a carcinogenic pathway by contributing to the metabolism of BP-7,8-diol, which increases production of fatal lung BPDE-dG; (iii) a filter comprising a scavenger of tobacco free radicals, which significantly reduces the production of BPDE-dG; And (iv) significantly reducing the function of the BPDE-dG adduct.

Compound quality . Proteinase K (EC 3.4.21.64, Tritirachium album) from Sigma (St. Louis, MO) and RNase Tl (EC 3.1.21.3, Aspergillus oryzae ) and RNase (DNase free, a heterogeneous mixture of ribonucleases from bovine pancreas) were obtained from Boehringer Mannheim (Mannheim, Germany). Phosphoric acid-buffered saline (PBS) was used for spectroscopy obtained from E. Merck, Darmstadt, Germany, 3.0 mM KCl, 1.5 mM KH ₂ HPO ₄ , 140 mM NaCl, 8.0 mM Na ₂ HPO ₄ , (pH 7.4), HPLC Grade water, MeOH, ether and ethanol. Unless otherwise stated, other compounds were obtained from Sigma (L'Isle d'Abeau Chesnes, France), Boehringer Ingelheim (Heidelberg, Germany) and Boehringer Mannheim (Mannheim, Germany). All BP metabolite standards were obtained from the National Cancer Institute, Chemical Carcinogen Reference Standard Repository Midwest Research Institute, Kansas City, Missouri.

Device. High performance liquid chromatography (HPLC) was performed using a Hewlett-Packard high pressure isocratic and gradient system (Waldborn, Germany) equipped with a Shimadzu RF-10AXL fluorescence detector connected to a Hewlett-Packard integrator. .

Preparation of Tobacco Smoke / PBS Solution ( CSS ). Smoking was done according to Pryor et al. Without a Cambridge filter. In principle, the same smoke collection method was used by Nakayama et al. 10 ml of phosphate-buffered saline (PBS) solution in which smoke formed during 8 cm burning per cigarette (Marlboro) catches both gaseous and tar tobacco smoke material with the help of a continuous vacuum formed in a water pump It was bubbled through. Since no water-insoluble tar compound was present on the wall of the water bottle, most of the water-soluble compounds derived from one tobacco smoke were contained in a 10 ml PBS solution. This aqueous solution, termed Tobacco Smoke Solution (CSS), is added to MCF-7 cells in culture in which benzo (a) pyrene or its similar metabolite (+)-BaP-7,8-diol is present, or exogenous. Immediate reaction with DNA. CSS was used at different dilution rates (see below).

Incorporation of Rosemary Powder Extract into Tobacco Filter . The normal tobacco filter was removed and 40 mg of rosemary powder extract was introduced at the location where the filter adjacent to the tobacco was removed. Thereafter, the filter was reinstalled. The efficacy of the filter was evaluated using mass spectroscopy. Tobacco smoke was bubbled in an organic solvent containing 3,3,5,5-tetramethyl-l-pyrroline-N-oxide (TMPO) spin trap adduct. The amount of hydroxyl radical adduct was then quantified using liquid chromatography, mass spectroscopy. In tobacco smoke conditions, a 30% reduction in hydroxyl radicals was observed.

Reaction of (+)- BP- 7,8- diol with exogenous DNA in the presence of diluted tobacco smoke solution ( CSS ) . 2 ml of calf thymus DNA (3 mg / ml) was added to 5 ml of 20-fold diluted CSS and 2 hours at room temperature with (+)-BP-7,8-diol (final concentration 3.6 μM) as shown in the following scheme Reacted during:

DNA + [(+)-BP-7,8-diol] + CSS → (-)-anti-BPDE-N ² -dG

The concentration of the resulting (-)-anti BPDE-dG adduct was measured (described below). As a control, the test was performed without CSS.

Cell Culture Conditions and Treatments. 150 in total volume 20 ml E-MEM (minimal essential medium) medium supplemented with 10% FCS, 15 mM Hepes buffer, and antibiotics (200 units / ml penicillin, 200 μg / ml streptomycin and 25 μg / ml ampicillin) Human breast cancer cell line MCF-7 was cultured in a -cm ² cell culture flask. Cells were treated, at 37 ° C., under 5% CO ₂ /95% atmosphere.

Once MCF-7 cells took up 90% of the flask area (2-3 days after separation of the fusion culture), the medium was replaced with 20 ml of fresh medium containing 10% serum. After 24 hours, at least 90% of nearly-fused cells, such as cells on GO / Gl, were treated with DMSO alone or with carcinogens dissolved in DMSO and tobacco smoke / PBS (CSS described above). The final concentration of DMSO did not exceed 0.1% of total culture volume. Control samples included in each culture set were treated with DMSO alone.

a) Treating MCF- 7 cells with (+)- BP- 7,8- diol and tobacco smoke . Cells were treated with (+)-BP-7,8-diol (0.2 μM) alone or in the presence of different CSS dilutions for 2 hours. (+)-BaP-7,8-diol was activated with R00 ° generated from CS and cell CYP's, producing (-)-anti-BPDE-dG and (+)-cin-BPDE-dG, respectively. These concentrations were measured by the formation of BP-tetrol I-1 and BP-tetrol II-2 (see below and FIG. 3).

b) Time / dose exposure test using BP . To characterize time / dose exposure to BP and BPDE-dG concentrations, cells (10 × 10 ⁶ cells / 150 cm ² flasks, 20 ml total volume) were added at final concentrations of 1.25, 2.5 for 6, 12, 18 and 24 hours, respectively. And 5.0 μM (2 flasks / dose / hour). The BPDE-dG adducts produced in the cells increased linearly in dose- and time-dependent form, as in the other cases (30). Based on these results, 2.5 μM was chosen as the running concentration for BP.

c) Treating MCF- 7 cells with BP and tobacco smoke . In order to confirm the efficacy according to the CS concentration, Test A of Experiment 1 was performed at different CSS dilution rates (1:79; 1:39; 1:19; 1: 9 vol / vol). Based on this test result, a dilution ratio of 1:19 (vol / vol) was selected for the CS run concentration. Thus, cells (see above "Cell Culture and Treatment") were treated with BP (2.5 μΜ) and CSS (1:19 vol / vol dilution) according to Experiment 1 (Figure 6-Experiment 1).

All cultures were repeated 2-3 times with duplicate samples. In the final step of the treatment, the morphological changes of the cells were examined under a microscope, followed by 0.05% trypsin-EDTA (0.05% trypsin, 0.14 M NaCl, 3 mM KCl, 0.1 M Na ₂ HPO ₄ , 1.5 mM K ₂ HPO ₄ , Collected by trypsinization with 0.5 mM EDTA). After addition to the same volume as the 10% FCS containing medium, cells were centrifuged at 1000 g, washed three times with PBS, and the cell pellet was frozen at -20 ° C. The viability of cells treated with BP and tobacco smoke or (+)-BP-7,8-diol and tobacco smoke was approximately 90% at the time of collection, as measured by trypan blue exclusion analysis. No cytotoxicity was seen at the dose used, as measured by lactate dehydrogenase activity assay (ELISA Kit, Boehringer, Mannheim).

DNA production and hydrolysis. DNA was isolated from MCF-7 cell pellets by treatment with RNase, proteinase K, salt process (31) and chloroform. Briefly, EDTA-sodium dodecyl sulfate (SDS) incubated at 37 ° C. for 1 hour using RNase Tl (2000 U / ml) and RNase A (without DNase; 100 μg / ml) in a shaker (100 rpm) ) Cell pellets were resuspended in buffer [10 mM Tris buffer, 1 mM Na ₂ EDTA, 1% SDS (w / v), pH 8]. Proteinase K (300 μg / ml) was then added and maintained at 37 ° C. overnight. After digestion, 6M NaCl was added to a final concentration of 1M and centrifuged at 10000 g. DNA in the supernatant was added to 2 vol. Settle with ethanol, wash with 70%, 100% ethanol, ether, dry and dissolve with 10 mM Tris buffer. In addition, KNase A (100 μg / ml) and RNase Tl (2000 U / ml) were added, and the solution was incubated at 37 ° C. for 1 hour and then proteinase K (100 μg / ml at 37 ° C. for an additional 2 hours. ) Was added and cultured. The solution was extracted once with chloroform, then centrifuged and the solution was made with 1M NaCl. DNA was precipitated with 2 vol. Of cold ethanol.

The hydrolyzed DNA portion was washed with 100% ethanol to remove unbound BP-tetrol. Unbound BP-tetrol-free DNA was dissolved in water and the DNA concentration was measured at A ₂₆₀ nm. Purity was determined by A ₂₆₀ / A ₂₈₀ and A ₂₆₀ / A ₂₃₀ ratio. For analysis, certain DNA was hydrolyzed by incubation at 90 ° C. for 4 hours at a final concentration of 0.1N HCl, as described above. This liberated tetrol (FIG. 3) from the BPDE-DNA adduct with> 90% recovery. The volume of the hydrolyzate for injection was set to 700 μl containing 5-10 μg DNA.

BPDE - N ² - dG adduct measured for density. R-7, c-9, t-8, t-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo (a) pyrene (BP-tetrol Il-l) as internal standard [34] The adduct concentration was measured using HPLC-FD as described above [32,33]. The hydrolyzate was placed on a latex pre-column module (HD-Germany) containing 5 μm C ₁₈ reversed phase material (nucleosil 100), equilibrated with 10% MeOH and washed with 12 ml 10% MeOH for 20 minutes. The pre-column was then turned on with a Valco Instruments switch valve to flow into a 5 μm C ₁₈ reversed phase (nucleosil 100) analytical column (Alltech GmbH, Unterhaching, Germany) at 4.6 mm × 25 cm. The product obtained by hydrolysis was eluted with the following MeOH / H ₂ O concentration gradient: 50%, 0-17 min; 50-60%, 17-32 minutes; 60%, 32-42 minutes; 60 to 100%, 42-57 minutes. The residence time of BP tetrol is as follows: BP tetrol I-1 (trans-anti-BP-tetrol) (35.2 min); BP-tetrol II-l (trans-cin-BP-tetrol), internal standard (36.9 min); BP Tetrol II-2 (cis-Cin-BP-Tetrol) (42.3 min). Fluorescence was measured at an excitation wavelength of 344 nm and an emission wavelength of 398 nm. Since no production of BP Tetrol II-l was detected in each assay for MCF-7 samples, BP Tetrol II-l was used as an internal standard (2 pg added to each HPLC analysis) to verify the relative retention time. It was. Detection limits were 0.5 pg of BP Tetrol I-1 and BP-Tetrol II-l. The level of each BP-tetrol was measured using a standard curve derived from the fluorescence peak area of the confirmed BP-tetrol standard analyzed immediately before analysis of the MCF-7 sample. After hydrolysis of the (+)-anti-BPDE-DNA adduct, BP-tetrol-I-1 was induced and detected. Hydrolysis of (−)-anti-BPDE-dG forms BP-tetrol I-2, but it is unstable and converted to BP-tetrol I-1 (FIG. 3) (38). Thus, the level of (-)-anti-BPDE-dG produced was determined by the amount of BP-tetrol I-1 identified in the HPLC analysis. Based on the discovery that BPDE reacting with DNA primarily produces BPDE-N ² -dG (7), it was assumed that BP-tetrol-I-1 level corresponds to that of BPDE-N ² -dG. The level of BPDE binding to MCF-7 DNA was quantified in duplicate. The level of adduct was calculated from the formula of 1 adduct per 1 pmol / mg DNA / 3.125 = 10 ⁶ nucleotides. HPLC analysis was quantitatively reproducible and the variability between the two assays was less than 5%.

The mechanism of mutation by BP is well defined and used as a "molecular signature" in establishing causal characteristics between specific genetic events on cancer development and oncogenic exposure ("critical evidence"). do. This "BP gene expression pattern" has an important relevance in precisely pointing out cigarette smoke as the cause of human lung cancer, and in creating specific strategies for minimizing or introducing preventive measures. Certain substances used in cancer chemotherapy appear to work by inhibiting the damage of carcinogens to DNA, mutations, tumor promotion and / or tumor progression.

In the present invention, the relative role of CS in biotransformation from BP-7,8-diol to BPDE capable of producing stable DNA adducts in human cells was investigated. Various studies have demonstrated that stable PAH-DNA adducts can mutate due to incorrect insertion or deletion of nucleotides. CS is an aerosol of a composite chemical composition comprising both organic and inorganic compounds, of which 4800 have been identified to date. It is known that both the vapor phase and the particulate phase of the smoke have free radicals. Gas phase radicals generally have a short lifespan, while radicals in the particulate phase are relatively stable and consist of hydroquinone, semiquinone and quinone complexes, which reduce molecular oxygen to produce superoxide and ultimately Is an active redox system capable of forming hydrogen peroxide and hydroxyl radicals. In addition, at least 60 other CS carcinogens have been involved in tumor initiation and promotion; The most potent carcinogens included in CS are BP and NNK (4- (methylnitrosamino) -1- (3-pyridyl) -1-butanone).

Cell-free systems involve additional DNA (Cell - Free Effect of Tobacco on (+)- anti - BPEP-dG using the System ) .

In order to elucidate the mechanism of production of reactive oxygen dependent BPDE-dG produced from tobacco smoke, this adduct was observed in an in vitro cell-free system involving DNA addition. CSS solution containing gaseous and tar tobacco smoke radicals reacted immediately with DNA in the presence of (+)-BP-7,8-diol (see protocol above). The test results show that CS oxidizes (+)-BP-7,8-diol to (-)-anti-BPDE, in other words forming a (-)-anti-BPDE-dG adduct. The amount of (−)-anti-BPDE-dG increased linearly and dose dependent (see FIG. 2).

Previously, it was confirmed that excess active oxygen, such as H ₂ O ₂ and O ₂ ⁻ , is generated from tobacco smoke trapped in PBS. Such active oxygen generated from tobacco smoke may result in the production of (-)-anti-BPDE-dG. To demonstrate this, the effects of catalase and superoxide dismutase (SOD) on the resulting (-)-anti-BPDE-dG were found to indicate that both enzymes inhibited the production of adducts. Inactive catalase had no effect (Table 1). From these results, the inventors have found that tobacco smoke oxidizes (+)-BP-7,8-diol, producing (-)-anti-BPDE-dG, which is primarily responsible for the oxygen produced from tobacco smoke. It was concluded that this could be explained by activity.

Effect of tobacco smoke on (-)- anti - BPDP - dG adducts produced in MCF- 7 cells treated with (+)- BP- 7,8- diol .

Two independent pathways that participate in metabolism from BP-7,8-diol to BPDE are shown in FIG. 3. Cytochrome p450-dependent metabolism of (+)-enantiomers preferentially produces (+)-new-BPDE, whereas pathways involving hamem-containing proteins coupled with peroxides (eg lipid peroxides) preferentially Produce (-)-anti-BPDE. (-)-BP-7,8-diol, on the other hand, can be metabolized via two pathways to produce the final forms of BP: (+)-anti-BPDE and (-)-new-BPDE. Since the tetrols from each of the anti- and shin-BPDEs are clearly separated under this condition, separate pathways can be distinguished by HPLC analysis.

Plays a role in the tobacco smoke dependent epoxidation of (+)-BP-7,8-diol, leading to the production of (-)-anti-BPDE forming a (-)-anti-BPDE-dG adduct with DNA For further study, human breast cancer cell line MCF-7 was used. The reason for using MCF-7 cells for the purpose of confirming the effect of tobacco smoke ROS on the activity of (+)-BP-7,8 diol is that these cells have almost no peroxide activity. These cells were treated with (+)-BP-7,8-diol, a stereochemical probe capable of distinguishing adducts formed by ROS and CYPs dependent pathways (FIG. 3). Two different peaks were observed in the chromatograms corresponding to BP-tetrol I and BP-tetrol II from (-)-anti-BPDE-dG and (+)-new-BPDE-dG, respectively (see 32- 34). Tobacco smoke reduced the CYPs dependent production of the (+)-neo-BPDE-dG adduct, as measured by the formation of BP-tetrol II, and reduced the ROS dependent production of (-)-anti-BPDE-dG. Dose-dependently increased (FIG. 4A). The reduction was also dose dependent and the inverse of the DNA adduct increased linearly with respect to the tobacco smoke concentration (4b). The inhibitory effect of CS on CYPs dependent formation of (+)-cin-BPDE-dG and increased formation of (-)-anti-BPDE-dG adducts was found in cigarette smoke upon formation of (-)-anti-BPDE-dG adducts. Identify the role of oxygen produced by

In other studies, induced CYPs activity was shown to be lowered by oxygen loading. The mechanism underlying such phenomena may be downregulation of the cytochrome P4501A1 gene. If there is little activity of the peroxide, MCF cells in the "stress" state can lead to increased DNA damage and reduced repair capacity. As a result, BPDE-DHA adducts may be increased independent of BP-7,8-diol activity.

BP Formed from cells treated with BPDE - dG  Effect of Tobacco Smoke on Adjuncts

Previous studies with MCF-7 cell cultures have shown that these cells have inducible P4501B1 and P4501A1 activity. The presence of P450 catalytic metabolic conversion of BP and the absence of detectable peroxide activity in MCF-7 cells allowed the role of tobacco smoke oxygen radicals on BP activity in human cell culture to be evaluated. MCF-7 cells have high CYPlAl enzymatic activity with respect to the metabolic activity of BP, which forms (-)-BP-7,8-diol and consequently forms (+)-anti-BPDE-dG (FIG. One). At 6 hours the level of adduct formation was significantly lower than the levels observed 12 and 24 hours after exposure. Approximately 2000 pg adducts were formed per mg DNA after treatment with 2.5 μM BP for 6 hours, but after 12 and 24 hours there were more than 11000 pg and 20000 pg adducts per mg DNA, respectively (Wilcoxon rank P = 0.0022 according to the Wilcoxon Rank Sum Test.

The cells were treated with BP for 12 and 18 hours to induce the formation of (-)-BP-7,8 diol, the substrate of ROS. The absence of BP-tetrol II derived from syn-BPDE in HPLC analysis with (+)-BP-7,8-diol as a precursor indirectly led to the selective formation of (-)-BP-7,8-diol. Confirm with (Fig. 3). The cells were then exposed with CSS to tobacco smoke for 2 hours with BP. As a result of HPLC analysis, only one peak was observed on the chromatogram corresponding to BP-tetrol I derived from (+)-anti-BPDE-dG. The difference between CSS treated and untreated cells (control) is shown in FIG. 5. As mentioned above, the cell lines used in this study retained the ability to reduce CYPlAl expression even after oxygen loading by CS. Inhibition of cytochrome P450 is thought to lower the activity of BP against (-)-BP-7,8-diol and (+)-anti-BPDE. Therefore, the difference according to CS becomes large because metabolism of (-)-BaP-7,8 diol is increased by ROS produced from CS. According to the Wilcoxon rank sum test, p = 0.0022 when treated with CS versus control for 14 and 20 hours, respectively. Recently, dramatic damage of DNA by BP has occurred in human bronchial epithelial cells that form BPDE-dG adducts, which can be considered “critical” for the initiation of human lung cancer bronchial epithelial cells. Thus, reactive oxygen species produced in tobacco smoke may play an important role in the formation of this “critical” adduct in bronchial epithelial cells (FIG. 1).

BPDK - dG  In the formation of adducts Rosemary  Effect of extract containing filter.

Rosemary ( Rosmarinus officinalis Labiatae ) herbs and oils are commonly used in food processing as spices and flavoring agents for the purpose of desired flavor and high antioxidant activity. Topical application of rosemary extract, carnasol or ursolic acid to mouse skin results in covalent binding of benzo (a) pyrene to epidermal DNA, by 7,12-dimethylbenz (a) anthracene (DMBA). Tumor initiation, TPA-induced tumor promotion, ornithine decarboxylase activity and inflammation are inhibited. Rosemary extracts have proven effective on the initiation phase as well as on the promotion phase. Rosemary extract, carnosic acid and carnosol strongly inhibit the activity of phase I enzyme CYP 450 and induce the expression of glutathione S-transferase (GST), phase II enzyme and the activity of quinone reductase. Carnosol inhibits the production of nitric oxide (NO) in active macrophages. Antioxidant properties are believed to form the mechanical basis of their protective action.

A small amount of rosemary powder was included in the standard filter for the purpose of removing free radicals and free radical species from tobacco smoke (see Materials section). The reduction of free radicals in the concentrate induced by the filter including the rosemary extract was evaluated by measuring the hydroxyl radical content of CSS with spin trap (TMPO) using LC-ESI-MS / MS. Under smoking conditions, a 30% reduction in hydroxyl radicals was observed. Due to the efficacy of the filter with reduced free radical levels in tobacco smoke compared to a standard Marlboro filter without additives, the formation of BPDE-dG using MCF-7 cells when passed through the filter compared to a standard filter The CS effect was compared.

When MCF-7 cells were treated with BP, the same results as shown in Fig. 6 were obtained. Two groups of tests were performed (A and B). Cells were treated with BP for 12 and 18 hours, respectively, followed by CSS from two filters with BP for an additional 2 hours (Experiment 1). To assess CYPs with increasing adducts for the additional 2 hours, two controls were used for each group: 12 and 14 hours for group A and 18 and 20 hours for group B. For CSS from standard filters, the level of binding obtained over 14 and 20 hours was doubled.

However, the rosemary filter interfered with the increase level obtained in the standard filter by more than 70% in the 2 groups (FIG. 6). As a result, ROS, a modified filter scavenger, reduces the activity of (-)-BP-7,8-diol (FIG. 3). In addition to the reduction of free radicals, rosemary powder may have other mechanisms that reduce BPDE-dG formation.

In addition, using whole rosemary extract (6 μg.ml ⁻¹ ), up to 80% inhibition of CYPlAl activity and the formation of DNA adducts 6 hours after co-culture with 1.5 μM BP in human bronchial epithelial cells (BEAS-2B) do. The use of a filter, thus reducing the amount of free radicals, thereby reducing the formation of deterministic carcinogenic adducts, is very beneficial for addiction smokers.

The rosemary tobacco filter according to the invention is therefore a promising candidate in a chemopreventive program aimed at reducing BPDE-dG in bronchial epithelial cells.

The foregoing description of the invention is susceptible to various modifications, changes and adaptations, and will be construed to include the same within the scope of equivalents of the invention claimed in the claims. An example of the most obvious variant is the use of various gel materials as the electroreactive composition.

Therefore, since the changes to the implementation of the method (process) are made without departing from the scope and spirit of the invention, the above-mentioned objects can be effectively achieved from those apparent from the above description, and all the implementations described herein It is to be understood that the examples are to be interpreted as illustrative and not intended to limit the scope of the invention.

It is also to be understood that the following claims are intended to cover all content included within the scope of the present invention, which is overlooked with all inclusive and unique features and linguistic matters described herein.

Claims (10)

A method of reducing benzo (a) pyrene diol epoxide-dG (BPDE-dG) adducts in human lungs, derived from tobacco smoke produced when smoking cigarettes with filters,
Passing the tobacco smoke through a filter saturated with an extract of Labiatae plants, wherein said extract comprises a polyphenol compound or a derivative thereof. The method of claim 1,
Said plant is rosemary. The method of claim 1,
Wherein said extract is produced by extraction with an alcoholic solvent or an aqueous-alcoholic solvent. A method of reducing benzo (a) pyrene diol epoxide-dG (BPDE-dG) adducts in human lungs, derived from tobacco smoke produced when smoking cigarettes with filters,
Passing the tobacco smoke through a filter saturated with a mixture comprising at least one polyphenol compound or derivative thereof. 5. The method of claim 4,
Wherein said mixture comprises at least one polyphenol compound or derivative thereof selected from the group consisting of carnosol, rosmanol, rosmarinic acid and carnosic acid. The method of claim 5,
Said mixture comprising carnosol, carnosic acid, rosemarine acid and rosemanol. The method according to claim 6,
Said mixture comprising carnosic acid or carnosol. The method of claim 7, wherein
Said filter comprising from 0.5 g to 0.1 mg of at least one polyphenol compound or derivative thereof. The method of claim 7, wherein
Said filter comprising 0.01 g of at least one polyphenol compound or derivative thereof. The method of claim 7, wherein
Wherein said at least one polyphenol compound or derivative thereof is bound to a polymeric carrier, contained in a microcapsule matrix, or added to the fibers of a filter.

Images